Security key
89422G107
Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX)
CUSIP: 89422G107
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 95,064,656
- Total 13F value
- $1,655,970,325
- Share change
- +10,816,032
- Put/Call ratio
- 65%
- SEC-reported price per share
- $17.42
- Number of holders
- 194
- Value change
- +$204,069,962
- Number of buys
- 112
- Number of sells
- 80
- Shares outstanding
- 92,930,114
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
194
Top holders
10
TVTX full security history
Ownership snapshot
Full 13F holder table
Travere Therapeutics, Inc. SEC filings
Travere Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TVTX - Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Woodline Partners LP
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
13D/G
Lead comparable stake: 2.4%
13D/G row: Woodline Partners LP
Showing 1-6 of 15 holder rows.
Quick read
Woodline Partners LP leads the comparable SEC ownership view at 2.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Woodline Partners LP's linked filing trail.
Comparable ownership
Top 5
Woodline Partners LP
2.4%
ARMISTICE CAPITAL, LLC
8.2%
BlackRock, Inc.
8.1%
VANGUARD GROUP INC
7.4%
Rock Springs Capital Management LP
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Woodline Partners LP |
13F
13D/G
Company
|
2.4%
from 13D/G
|
$60,721,357
4,340,340 shares
|
— | 30 Sep 2024 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
8.2%
|
$106,995,520
7,648,000 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
8.1%
|
$105,728,768
7,557,453 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
7.4%
|
$96,561,078
6,902,150 shares
|
— | 30 Sep 2024 |
| Rock Springs Capital Management LP |
13F
Company
|
5%
|
$65,535,819
4,684,476 shares
|
— | 30 Sep 2024 |
| MACQUARIE GROUP LTD |
13F
Company
|
4.6%
|
$59,778,000
4,272,914 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
194
Shares
95,064,656
Rows available
194
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
175
Q4 2024 holders
194
Holder diff
19
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|